Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

UK Digital PCR (dPCR) and Real-Time PCR (qPCR) Market 2019-2025

Published by Orion Market Research Pvt Ltd Product code 947836
Published Content info
Delivery time: 2-3 business days
Price
Back to Top
UK Digital PCR (dPCR) and Real-Time PCR (qPCR) Market 2019-2025
Published: March 29, 2020 Content info:
Description

UK Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, By Technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software), By Application (Research Application, Clinical Application, and Forensic Application) and Forecast, 2019-2025

UK digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 7.6% during the forecast period. UK is estimated to have a significant market for the dPCR and qPCR technology and solutions during the forecast period. Major factors augmenting the market growth include on-going researches in academic research institutes and research centers coupled with a significant prevalence of cancer, hemophilia B and CVD in the nation. The healthcare expenditure of the UK is higher as compared to Germany and France. This is one of the major factors that tend to rise the dPCR and qPCR market in UK, as the government is focusing on advanced diagnostic procedures for chronic diseases, including cancer and CVD.

AS per OECD, the prevalence of cancer in the UK is approximately 225 per 100,000 people in 2011 which reduced only to 214 per 100,000 people in 2017. This decrease in the prevalence rate is backed by the increasing adoption of advanced technologies for the diagnostic procedures, which includes dPCR and qPCR technology. Owing to the significant prevalence of cancer and CVD across the country, the organizations in the country such as Cancer Research Institute is investing in R&D of new technologies to promote the effective treatment of cancer across the country. Owing to this, in 2017, Cancer Research UK, launched the next round of the grand challenge, which is a series of $26 million awards for national and international teams to innovate and improve treatment responses by manipulating the composition and status of the microbiota. Such innovations are expected to further promote the growth of the market in the coming years.

The companies operating in the market include Qiagen N.V., LGC Ltd., Analytik Jena AG, Eppendorf AG, Merck KGaA, and Thermo Fisher Scientific Inc. These players are adopting crucial strategies, including mergers and acquisitions, partnerships and collaborations, and product launches, to expand market share and gain a competitive advantage. For instance, in July 2018, Qiagen N.V. established partnerships with multiple organizations for creating a global genomics campus in Manchester, UK for translational science, molecular diagnostics and life sciences. These collaborations would leverage the expertise of the company for accelerating innovation for developing valuable molecular tests. This is estimated to provide growth opportunities to the market players in the country to expand their services in the market.

Research Methodology

The market study of the UK dPCR and qPCR market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include::

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. It will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

  • UK dPCR and qPCR Market Research and Analysis, By Technology
  • UK dPCR and qPCR Market Research and Analysis, By Product
  • UK dPCR and qPCR Market Research and Analysis, By Application

The Report covers:

  • Comprehensive research methodology of the UK dPCR and qPCR market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the UK dPCR and qPCR market.
  • Insights about market determinants which are stimulating the UK dPCR and qPCR market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.
Table of Contents
Product Code: OMR2021267

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. UK dPCR and qPCR Market by Technology
    • 5.1.1. Quantitative PCR (qPCR)
    • 5.1.2. Digital PCR (dPCR)
  • 5.2. UK dPCR and qPCR Market by Product
    • 5.2.1. Reagents and Consumables
    • 5.2.2. Instruments
    • 5.2.3. Software
  • 5.3. UK dPCR and qPCR Market by Application
    • 5.3.1. Research Application
    • 5.3.2. Clinical Application
    • 5.3.3. Forensic Application

6. Company Profiles

  • 6.1. Analytik Jena AG
  • 6.2. BioMerieux S.A.
  • 6.3. Bio-Rad Laboratories, Inc.
  • 6.4. Danaher Corp.
  • 6.5. Eppendorf AG
  • 6.6. F. Hoffmann-La Roche AG
  • 6.7. LGC Ltd.
  • 6.8. Merck KGaA
  • 6.9. Qiagen N.V.
  • 6.10. Siemens AG
  • 6.11. Thermo Fisher Scientific Inc.

List of Tables

  • 1. UK DPCR AND QPCR MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 2. UK DPCR AND QPCR MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
  • 3. UK DPCR AND QPCR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

List of Figures

  • 1. UK DPCR AND QPCR MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)
  • 2. UK DPCR AND QPCR MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)
  • 3. UK DPCR AND QPCR MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
Back to Top